Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
by
Aronov, Alex M
, Shih, Hsin-pei
, Zhang, Xiaodan
in
Pharmaceutical industry
/ Productivity
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
by
Aronov, Alex M
, Shih, Hsin-pei
, Zhang, Xiaodan
in
Pharmaceutical industry
/ Productivity
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
Journal Article
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
2018
Request Book From Autostore
and Choose the Collection Method
Overview
The productivity of the pharmaceutical industry has been widely discussed in recent years, particularly with regard to concerns that substantial expenditures on research and development have failed to translate into approved drugs. Various analyses of this productivity challenge have focused on aspects such as attrition rates at particular clinical phases or the physicochemical properties of drug candidates, but relatively little attention has been paid to how the industry has performed from the standpoint of the choice of therapeutic mechanisms and their intended indications. This article examines what the pharmaceutical industry has achieved in this respect by analysing comprehensive industry-wide data on the mechanism-indication pairs that have been investigated during the past 20 years. Our findings indicate several points and trends that we hope will be useful in understanding and improving the productivity of the industry, including areas in which the industry has had substantial success or failure and the relative extent of novelty in completed and ongoing projects.
Publisher
Nature Publishing Group
Subject
This website uses cookies to ensure you get the best experience on our website.